EMG
IBIO icon

ETF Managers Group’s iBio IBIO Stock Holding History

ETF Managers Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-138
Closed -$19K – 753
2022
Q2 		$19K Buy
138
+6
+5% +$902 ﹤0.01% 736
2022
Q1 		$29K Hold
132
– – ﹤0.01% 677
2021
Q4 		$38K Sell
132
-21
-14% -$8.01K ﹤0.01% 672
2021
Q3 		$81K Buy
153
+24
+19% +$14.9K ﹤0.01% 645
2021
Q2 		$96K Sell
129
-3
-2% -$2.19K ﹤0.01% 622
2021
Q1 		$99K Sell
132
-45
-25% -$39.2K ﹤0.01% 638
2020
Q4 		$97K Sell
177
-19
-10% -$15.5K ﹤0.01% 601
2020
Q3 		$205K Buy
196
+118
+151% +$171K 0.01% 574
2020
Q2 		$96K Buy
+78
New +$51K ﹤0.01% 586

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ETF Managers Group's IBIO Position: Q3 2022 in Review

ETF Managers Group sold out of iBio (IBIO) in Q3 2022, closing a stake of 138 shares — an estimated $19K sold.

ETF Managers Group first reported a position in IBIO in Q2 2020 and held it in 9 quarters. The position peaked at $205K in Q3 2020. 43 funds tracked by Wall St. Rank hold IBIO as of Q3 2022.

  • ETF Managers Group reported no remaining iBio position as of Q3 2022 after selling out during the quarter.
  • ETF Managers Group sold 138 iBio shares in Q3 2022, an estimated $19K.
  • ETF Managers Group first reported a position in iBio in Q2 2020 and held it in 9 quarters.
  • ETF Managers Group's iBio position peaked at $205K in Q3 2020.
  • 43 funds tracked by Wall St. Rank held iBio as of Q3 2022.

Based on ETF Managers Group's 13F filing for Q3 2022, filed 14 Nov 2022.